½ÃÀ庸°í¼­
»óǰÄÚµå
1609125

¼¼°èÀÇ NGS ŰƮ ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

NGS Kits Market by Type (Amplicon Sequencing Kits, ChIP Sequencing Kits, Epigenetic Sequencing Kits), Application (Targeted Sequencing, Whole Genome Sequencing), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

NGS ŰƮ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 22¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 24¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.26%·Î ¼ºÀåÇØ 2030³â¿¡´Â 34¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

NGS ŰƮ¿¡ ´ëÇÑ ½ÃÀå Á¶»çÀÇ ´ë»ó ¹üÀ§´Â DNA ¶Ç´Â RNA »ùÇÃÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ ºÐ¼®À» ÃËÁøÇϱâ À§ÇØ À¯ÀüüÇп¡¼­ ³Î¸® »ç¿ëµÇ´Â Â÷¼¼´ë ½ÃÄö½Ì ŰƮÀÇ º¹À⼺À» ÀÌÇØÇÏ´Â °ÍÀÔ´Ï´Ù. Á¾ÇÕÀûÀÎ À¯Àüü ÇØ¼®À» ÅëÇØ »ý¹°°úÇп¡ Çõ¸íÀ» °¡Á®¿À°í, Á¤¹ÐÀÇ·á, Á¾¾çÇÐ, ³ó¾÷À¯ÀüüÇÐ, °¨¿°Áõ µîÀÇ ºÐ¾ßÀÇ ¿¬±¸¸¦ °­È­ÇÏ´Â ´É·Â¿¡¼­ »ý±é´Ï´Ù. ÀÌ Å°Æ®´Â Çмú ¿¬±¸, ÀÓ»ó Áø´Ü, Á¦¾à, ¹ÙÀÌ¿À Å×Å©³î·ÎÁö »ê¾÷ µî¿¡ ÀÀ¿ëµÇ¾î °úÇÐÀ̳ª ÇコÄɾ ºÒ°¡°áÇÑ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ±â¼ú Áøº¸, ½ÃÄö½Ì ºñ¿ë Àý°¨, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, À¯Àüü ÇÁ·ÎÁ§Æ® ±ÞÁõ µîÀÌ ÀÖ½À´Ï´Ù. ºñħ½ÀÀû Ãâ»ý Àü °Ë»ç¿Í µ¿¹ÝÀÚ Áø´Ü¿¡¼­ NGS ±â¼úÀÇ ÀÀ¿ë È®´ë¿¡´Â ÁÖ¸ñÇÒ ¸¸ÇÑ ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. Ȱ¿ëÇØ¾ß ÇÕ´Ï´Ù. ±×·¯³ª °úÁ¦·Î´Â Ãʱ⠼³Á¤ ºñ¿ëÀÇ ³ôÀÌ, ´ë·®ÀÇ µ¥ÀÌÅÍ Ãâ·Â¿¡ ÀÇÇÑ µ¥ÀÌÅÍ °ü¸®ÀÇ ¹®Á¦, º¹ÀâÇÑ °á°ú¸¦ ÇØ¼®Çϱâ À§ÇÑ ¼÷·Ã ±â¼úÀÚÀÇ Çʿ伺 µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄÝÀÌ ¾ø´Â °Íµµ ÀÌ·¯ÇÑ ±â¼úÀÇ º¸±ÞÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. º¸´Ù ´Ü¼øÇÑ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¼Ö·ç¼ÇÀ» °®Ãá ºñ¿ë È¿À²ÀûÀΠŰƮ °³¹ß¿¡ ÁßÁ¡À» µÑ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÄö½Ì ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ ºÐ¼® Ç÷§Æû°úÀÇ ÅëÇÕÀ» °³¼±ÇÔÀ¸·Î½á »õ·Î¿î ¿¬±¸ °æ·Î¿Í ºñÁî´Ï½º ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Áøº¸, ÇÕº´, Àμö ´Â Áö¼ÓÀûÀ¸·Î ½ÃÀå Àü·«À» ÀçÁ¤ÀÇÇÏ´Â °æÀï ȯ°æÀ» Ư¡À¸. Ž»öÇϰí ÀÚ¿ø ¹èºÐÀ» È¿°úÀûÀ¸·Î ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 22¾ï 8,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 24¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 34¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 6.26%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â NGS ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

NGS ŰƮ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ±×¸®°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò±â À§ÇØ Áغñ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ÀÌ´Â Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ À¯Àü¼º Áúȯ°ú °¨¿°ÁõÀÇ À¯Çà
    • Á¤¹ÐÀÇ·á ¹× ºÐÀÚÁø´Ü¿¡¼­ÀÇ ÀÀ¿ë Áõ°¡
    • ºñ¿ë È¿À²ÀûÀΠâ¾à °³¹ß ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·°ú Ãʱâ ÅõÀÚÀÇ ³ôÀÌ
  • ½ÃÀå ±âȸ
    • À¯Àüü °úÇÐ ºÐ¾ß¿¡¼­ÀÇ ¿¬±¸ Á¶¼º Ȱµ¿ÀÇ È®´ë
    • NGS ±â¼úÀÇ Áøº¸¿Í ½Å±Ô¼ºÀÇ ¼Ò°³
  • ½ÃÀåÀÇ °úÁ¦
    • µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺, Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄݰú ǰÁú °ü¸®ÀÇ ºÎÁ·

Porter's Five Force : NGS ŰƮ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : NGS ŰƮ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº NGS ŰƮ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : NGS ŰƮ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

NGS ŰƮ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐ¸í ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÑ Áö°ß ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : NGS ŰƮ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â NGS ŰƮ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±âº» °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : NGS ŰƮ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

NGS ŰƮ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • À¯Àü¼º Áúȯ°ú °¨¿°ÁõÀÇ ¼¼°èÀÇ ¸¸¿¬
      • Á¤¹ÐÀÇ·á¿Í ºÐÀÚÁø´Ü¿¡ À־ÀÇ ÀÀ¿ë Áõ°¡
      • ºñ¿ëÈ¿°ú°¡ ³ôÀº ÀǾàǰÀÇ ¹ß°ß°ú °³¹ß ¼Ö·ç¼Ç ¼ö¿ä
    • ¾ïÁ¦¿äÀÎ
      • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·°ú Ãʱâ ÅõÀÚÀÇ °í¾×È­
    • ±âȸ
      • À¯Àüü °úÇÐ ºÐ¾ßÀÇ Á¶»ç ÀÚ±Ý È°µ¿ È®´ë
      • NGS ±â¼úÀÇ Áøº¸¿Í ½Å±â¼úÀÇ ¼Ò°³
    • °úÁ¦
      • µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺°ú Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄݰú ǰÁú °ü¸®ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå NGS ŰƮ ½ÃÀå : À¯Çüº°

  • ¾ÚÇø®ÄÜ ½ÃÄö½Ì ŰƮ
  • ChIP ½ÃÄö½Ì ŰƮ
  • ÈļºÀû ½ÃÄö½Ì ŰƮ
  • ¶óÀ̺귯¸® Á¶Á¦ ŰƮ
  • ¸ÞŸÀ¯Àüü ½ÃÄö½Ì ŰƮ
  • ¼ÒÇü RNA ½ÃÄö½Ì ŰƮ

Á¦7Àå NGS ŰƮ ½ÃÀå : ¿ëµµº°

  • Ÿ°Ù ½ÃÄö½Ì
  • Àüü À¯Àüü ¼­¿­ ½ÃÄö½Ì

Á¦8Àå NGS ŰƮ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú±â°ü ¹× ¿¬±¸¼¾ÅÍ
  • º´¿ø ¹× Ŭ¸®´Ð
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ·¹ÆÛ·±½º ·¦

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ NGS ŰƮ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ NGS ŰƮ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ NGS ŰƮ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Creative Biogene
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Illumina, Inc.
  • New England Biolabs
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • seqWell
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corporation
JHS 24.12.20

The NGS Kits Market was valued at USD 2.28 billion in 2023, expected to reach USD 2.44 billion in 2024, and is projected to grow at a CAGR of 6.26%, to USD 3.49 billion by 2030.

The scope of the market research on NGS Kits involves understanding the intricacies of next-generation sequencing kits used broadly in genomics to facilitate rapid and precise analysis of DNA or RNA samples. The necessity of NGS Kits arises from their capacity to revolutionize biological sciences through comprehensive genomic analysis, enhancing research in fields such as precision medicine, oncology, agrigenomics, and infectious diseases. The kits are applied across academic research, clinical diagnostics, pharmaceuticals, and biotechnology industries, making them indispensable in scientific and healthcare settings. Key factors influencing the growth of the NGS Kits market include technological advancements, decreasing costs of sequencing, increasing demand for personalized medicine, and a surge in genomic projects. A notable opportunity exists in the expanding application of NGS technology in non-invasive prenatal testing and companion diagnostics. Companies should capitalize on government funding for genomics research and partnerships with healthcare institutions to foster growth. However, challenges include the high initial setup costs, data management issues due to the voluminous data outputs, and the need for skilled personnel to interpret complex results. There is also a lack of standardized protocols which could impede the wider adoption of these technologies. Innovations could focus on developing cost-effective kits with increased throughput, enhanced accuracy, and simpler bioinformatics solutions to address data management challenges. Furthermore, streamlining the sequencing workflow and improving integration with cloud-based data analytics platforms can provide new research avenues and business growth opportunities. The NGS Kits market is dynamic in nature, characterized by rapid technological advancements and a competitive landscape where mergers and acquisitions continually redefine market strategies. Emphasizing collaborations between stakeholders could bridge gaps in knowledge and technology, leveraging data-driven insights to navigate market challenges and optimize resource allocation effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 2.28 billion
Estimated Year [2024] USD 2.44 billion
Forecast Year [2030] USD 3.49 billion
CAGR (%) 6.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS Kits Market

The NGS Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of genetic disorders and infectious diseases worldwide
    • Increasing application in precision medicine and molecular diagnostics
    • Demand for cost-effecting drug discovery and development solution
  • Market Restraints
    • Lack of skilled professionals and initial high investment
  • Market Opportunities
    • Growing research funding activities in the field of genome science
    • Introduction of advancement and novel in NGS technology
  • Market Challenges
    • Complexity of data analysis and the lack of standardized protocols and quality control

Porter's Five Forces: A Strategic Tool for Navigating the NGS Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS Kits Market

A detailed market share analysis in the NGS Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS Kits Market

A strategic analysis of the NGS Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS Kits Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Creative Biogene, Danaher, F. Hoffmann-La Roche Ltd, Hologic, Inc., Illumina, Inc., New England Biolabs, Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc., Promega Corporation, QIAGEN N.V., seqWell, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the NGS Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Amplicon Sequencing Kits, ChIP Sequencing Kits, Epigenetic Sequencing Kits, Library Preparation Kits, Metagenomic Sequencing Kits, and Small RNA Sequencing Kits.
  • Based on Application, market is studied across Targeted Sequencing and Whole Genome Sequencing.
  • Based on End User, market is studied across Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of genetic disorders and infectious diseases worldwide
      • 5.1.1.2. Increasing application in precision medicine and molecular diagnostics
      • 5.1.1.3. Demand for cost-effecting drug discovery and development solution
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professionals and initial high investment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing research funding activities in the field of genome science
      • 5.1.3.2. Introduction of advancement and novel in NGS technology
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity of data analysis and the lack of standardized protocols and quality control
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. NGS Kits Market, by Type

  • 6.1. Introduction
  • 6.2. Amplicon Sequencing Kits
  • 6.3. ChIP Sequencing Kits
  • 6.4. Epigenetic Sequencing Kits
  • 6.5. Library Preparation Kits
  • 6.6. Metagenomic Sequencing Kits
  • 6.7. Small RNA Sequencing Kits

7. NGS Kits Market, by Application

  • 7.1. Introduction
  • 7.2. Targeted Sequencing
  • 7.3. Whole Genome Sequencing

8. NGS Kits Market, by End User

  • 8.1. Introduction
  • 8.2. Academic Institutes & Research Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Pharmaceutical & Biotechnology Companies
  • 8.5. Reference Laboratories

9. Americas NGS Kits Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific NGS Kits Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa NGS Kits Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. BGI Group
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Creative Biogene
  • 5. Danaher
  • 6. F. Hoffmann-La Roche Ltd
  • 7. Hologic, Inc.
  • 8. Illumina, Inc.
  • 9. New England Biolabs
  • 10. Oxford Nanopore Technologies plc.
  • 11. Pacific Biosciences of California, Inc.
  • 12. PerkinElmer Inc.
  • 13. Promega Corporation
  • 14. QIAGEN N.V.
  • 15. seqWell
  • 16. Takara Bio Inc.
  • 17. Tecan Trading AG
  • 18. Thermo Fisher Scientific, Inc.
  • 19. Twist Bioscience Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦